Evangelia K. Papachristou

Robinson Way
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

The transcription factor BACH1 couples chromatin priming and repression to enable macrophage plasticity and adaptation.

The transcription factor BACH1 couples chromatin priming and repression to enable macrophage plasticity and adaptation.

Journal: Immunity
Published: May 29, 2025

Tandem Duplications in UBTF Create XPO1-Dependent Nuclear Export Signals that Reveal a Leukemic Therapeutic Dependency.

Tandem Duplications in UBTF Create XPO1-Dependent Nuclear Export Signals that Reveal a Leukemic Therapeutic Dependency.

Journal: Blood cancer discovery
Published: April 01, 2025

KAT6A and KAT7 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in NUP98-Rearranged Acute Myeloid Leukemia.

KAT6A and KAT7 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in NUP98-Rearranged Acute Myeloid Leukemia.

Journal: Cancer discovery
Published: December 06, 2024

Comparative ASCL1 Interactome Analysis Reveals CDK2-Cyclin A2 as Suppressors of Differentiation in MYCN-Amplified Neuroblastoma.

Comparative ASCL1 Interactome Analysis Reveals CDK2-Cyclin A2 as Suppressors of Differentiation in MYCN-Amplified Neuroblastoma.

Journal: Molecular cancer research : MCR
Published: October 08, 2024

Posttranscriptional depletion of ribosome biogenesis factors engenders therapeutic vulnerabilities in NPM1-mutant AML.

Posttranscriptional depletion of ribosome biogenesis factors engenders therapeutic vulnerabilities in NPM1-mutant AML.

Journal: Blood
Published: July 12, 2024

ZBTB7A is a modulator of KDM5-driven transcriptional networks in basal breast cancer.

ZBTB7A is a modulator of KDM5-driven transcriptional networks in basal breast cancer.

Journal: Cell reports
Published: April 11, 2024

Transcription factor switching drives subtype-specific pancreatic cancer.

Transcription factor switching drives subtype-specific pancreatic cancer.

Journal: Nature genetics
Published: February 17, 2024

Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma.

Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma.

Journal: Cancer discovery
Published: July 15, 2023

CRISPR-Cas9 genetic screen leads to the discovery of L-Moses, a KAT2B inhibitor that attenuates Tunicamycin-mediated neuronal cell death.

CRISPR-Cas9 genetic screen leads to the discovery of L-Moses, a KAT2B inhibitor that attenuates Tunicamycin-mediated neuronal cell death.

Journal: Scientific reports
Published: December 11, 2022

Multi-omics analyses demonstrate a critical role for EHMT1 methyltransferase in transcriptional repression during oogenesis.

Multi-omics analyses demonstrate a critical role for EHMT1 methyltransferase in transcriptional repression during oogenesis.

Journal: Genome research
Published: June 20, 2022

ZNF384 Fusion Oncoproteins Drive Lineage Aberrancy in Acute Leukemia.

ZNF384 Fusion Oncoproteins Drive Lineage Aberrancy in Acute Leukemia.

Journal: Blood cancer discovery
Published: September 02, 2021

The renal lineage factor PAX8 controls oncogenic signalling in kidney cancer.

The renal lineage factor PAX8 controls oncogenic signalling in kidney cancer.

Journal: Nature
Published: February 11, 2021
Showing 1-12 of 28

Last Updated: 09/26/2026